Silvano Francisco Mariano, a fentanyl manufacturer for the Chapitos cartel, pleaded guilty to fentanyl trafficking in a New York federal court [1].
This cooperation provides U.S. authorities with an insider's perspective on the production chain of synthetic opioids, a critical component in the ongoing effort to dismantle the Sinaloa cartel's infrastructure.
Mariano, who uses the alias "El Rayo," coordinated the production of fentanyl in labs located in Sinaloa, Mexico [1]. His operational activity took place between 2022 and 2023 [1]. By pleading guilty, Mariano has agreed to serve as a key witness for prosecutors in a large-scale trafficking investigation that began in 2023 [1].
The agreement with federal prosecutors resulted in a significantly reduced prison term for the manufacturer. Prosecutors originally sought a 14-year prison term [1]. However, due to his cooperation, the judge sentenced him to seven years in prison [1].
The case highlights the U.S. strategy of flipping high-level operational leads to secure testimony against cartel leadership. Mariano's role as a manufacturer places him in a position to verify the chemicals, precursors, and logistics used by the Chapitos faction, the sons of Joaquín "El Chapo" Guzmán.
Federal investigators have focused on the synthesis of fentanyl due to its high potency and the resulting public health crisis in the U.S. The testimony provided by Mariano is expected to link specific production sites in Mexico to distribution networks within the United States [1].
“Silvano Francisco Mariano will serve as a key witness for U.S. authorities.”
The reduced sentence for 'El Rayo' underscores the high value the U.S. Department of Justice places on technical intelligence. By securing a witness who managed the actual chemistry and logistics of fentanyl production, prosecutors can move beyond simple seizure data to prove the intentionality and organizational structure of the Chapitos cartel.
